home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  FS Zollmann: HUM-MOLGEN News Alert - November 30, 2005  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: list@hum-molgen.de
Subject: HUM-MOLGEN News Alert - November 30, 2005
From: FS Zollmann <zollmann@hum-molgen.de>
Date: Wed, 30 Nov 2005 13:58:10 +0100

__________________________________________________________________________

   DRUG DISCOVERY TECHNOLOGY EUROPE 2006
   Conference & Exhibition

   13-16 March 2006 - London, UK

   http://hum-molgen.org/promotion-DDT
__________________________________________________________________________


INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS
HUM-MOLGEN News Alert - November 30, 2005 - http://hum-molgen.org


DIAGnostics - Clinical Research (professional requests)
http://hum-molgen.org/clinical-research/

- Testing for BRCA1 and 2 (University of Colombo, Sri Lanka)
    http://hum-molgen.org/bb/Forum2/HTML/000185.html

- Post diagnostic request / call for collaboration
   http://hum-molgen.org/diagnostic-posting or
   contact admin@hum-molgen.org


Genetic News
by T.M. D'Souza, S. Chandler, T. Dalaya, K. Markey, J. Mill, R. Nemade,
D. Sharma, F.S. Zollmann
http://hum-molgen.org/NewsGen

- World Community Grid Targets AIDS in Giant Research Effort
    Second project will help determine effective AIDS therapies
    http://hum-molgen.org/NewsGen/11-2005/msg62.html

- 9/11 Panel Makes Recommendations for DNA-Based Identification After
   Mass Disasters
    Team Effort Identified 850 World Trade Center Victims
    http://hum-molgen.org/NewsGen/11-2005/msg61.html

- Earliest Animals Had Human-like Genes
     Species evolve at very different rates, and the evolutionary line
    that produced humans seems to be among the slowest.
    http://hum-molgen.org/NewsGen/11-2005/msg60.html

- Alzheimer's Vaccine Reviewed
    A controversial vaccine that was the subject of a halted trial to
    prevent cognitive decline in Alzheimer's patients could have the
    potential to be reformulated to eliminate its toxicity while
    retaining the benefits.
    http://hum-molgen.org/NewsGen/11-2005/msg59.html

- A Silent Killer
    Scientists suggest a mechanism that may selectively silence the
    electrical activity of dopamine producing neurons.
    http://hum-molgen.org/NewsGen/11-2005/msg58.html

- Remote-Controlled Gene Delivery
    Synthetic gene-delivery system has great implications for the
    development of targeted gene therapy based on non-viral systems.
    http://hum-molgen.org/NewsGen/11-2005/msg57.html

- Visualizing Suppression Of Autoimmune Disease
    Scientists have devised a way to view how autoimmunity is averted.
    http://hum-molgen.org/NewsGen/11-2005/msg56.html

- Perfect Fit For Immune Recognition
    Mice lacking a particular enzyme exhibit abnormal immune responses,
    resulting from a less than perfect fit of protein bits displayed to
    immune cells.
    http://hum-molgen.org/NewsGen/11-2005/msg55.html

- Activating Smoothened
    Scientists report on the protein target of a small molecule known to
    induce stem cell differentiation.
    http://hum-molgen.org/NewsGen/11-2005/msg54.html

- Polycystic Kidney Disease Unravelled
    New results unravel how two mutated genes operate in causing abnormal
    cell proliferation in autosomal dominant polycystic kidney disease
    (ADPKD).
    http://hum-molgen.org/NewsGen/11-2005/msg53.html

- DISC1, Neuronal Development And Schizophrenia
    A change in the function of a protein in the cerebral cortex may
    contribute to the subtle neuronal defects observed in the brains of
    patients with schizophrenia.
    http://hum-molgen.org/NewsGen/11-2005/msg52.html

- siRNA-Based Microbicide Stops Herpes
    Scientists have developed a microbicide that protects mice against
    the lethal genital herpesvirus (HSV-2).
    http://hum-molgen.org/NewsGen/11-2005/msg51.html

- Molecular Diagnosis Of Human Cancer Type By Gene Expression Profiles
   And Independent Component Analysis
    Scientists have devised a novel pattern recognition procedure based
    on independent component analysis (ICA).
    http://hum-molgen.org/NewsGen/11-2005/msg50.html

- Analysis Of Four Neuroligin Genes As Candidates For Autism
    Researchers conclude that neuroligin mutations most probably
    represent rare causes of autism.
    http://hum-molgen.org/NewsGen/11-2005/msg49.html

- Mutation Analysis Of The WFS1 Gene In Seven Danish Wolfram Syndrome
   Families; Four New Mutations Identified
    Four new mutations have been identified in the WFS1 gene associated
    with autosomal recessive (AR) wolfram syndrome (WS).
    http://hum-molgen.org/NewsGen/11-2005/msg48.html

- The Phenotype Of Second And Third Toe Syndactyly Maps To Chromosome
   3p21.31
    The authors propose to group the type I syndactyly condition into
    four subtypes, which are all autosomal dominantly inherited.
    http://hum-molgen.org/NewsGen/11-2005/msg47.html

- Novel And De Novo Mutations Of The IRF6 Gene Detected In Patients With
   Van Der Woude Or Popliteal Pterygium Syndrome
    Scientists report 10 mutations in Van der Woude (VWS) and popliteal
    pterygium syndrome (PPS) genes.
    http://hum-molgen.org/NewsGen/11-2005/msg46.html

- Mutation Spectrum Leading To An Attenuated Phenotype In
   Dystrophinopathies
    Study characterizes mRNA changes associated with five novel point
    mutations giving rise to a Becker muscular dystrophy (BMD) phenotype.
    http://hum-molgen.org/NewsGen/11-2005/msg45.html

- Engineered Zinc Finger Proteins make the Heart Beat Stronger
    The use of an engineered zinc finger transcriptional repressor offers
    a new avenue of attack for congestive heart failure patients
    http://hum-molgen.org/NewsGen/11-2005/msg43.html

- Promising pancreatic cancer data from a genetically engineered vaccine
    Non-patient specific GVAX data for pancreatic cancer points to
    impressive efficacy using GM-CSF mediated T cell activation
    http://hum-molgen.org/NewsGen/11-2005/msg42.html

- Contact Genetic News editors
   WWW: http://hum-molgen.org/editors.html
   E-mail: news@hum-molgen.org


Biomedical Positions
http://hum-molgen.org/positions/

- Cell and Molecular Biology / Anatomy: post-doctoral fellow
    Toronto Western Research Institute, Toronto, Canada
    http://hum-molgen.org/positions/postdocs/2604.html

- Genetics: post-doctoral fellow
    Stellenbosch University, Stellenbosch, South Africa
    http://hum-molgen.org/positions/postdocs/2605.html

- Microbiology / Virology: Post-doctoral research position available to
   study antiviral immune response in the lung mucosa
    Institut Pasteur / Inserm E336, Paris, France
    http://hum-molgen.org/positions/postdocs/2606.html

- Call for Assistant News Editors
   To further strengthen our news section we are currently looking for:
   Assistant Editors for the HUM-MOLGEN News section
   http://hum-molgen.org/NewsGen/04-2003/msg01.html

- Write a position announcement
   http://hum-molgen.org/flyer/positions.pdf
   1) Set up account: http://hum-molgen.de/cgi-bin/positions.pl?register
   2) Post position(s): http://hum-molgen.de/cgi-bin/positions.pl?login


Biotechnical requests and sources
http://hum-molgen.org/biotechnology

- Investors in Therapeutic biopharma manufacture in Kerala, India
    http://hum-molgen.org/bb/Forum1/HTML/000157.html

- Call for Collaboration / Business outscourcing (Pune, India)
    http://hum-molgen.org/bb/Forum1/HTML/000158.html


Literature
http://hum-molgen.org/literature/


Events in bioscience and medicine
http://hum-molgen.org/meetings/

- Post event (free)
   http://hum-molgen.de/cgi-bin/meetings.pl?login


Registry of Biomedical Companies (1243 active entries)
http://hum-molgen.org/companies/


Mailing List Administration (Join or leave the list)
http://hum-molgen.org/subscribe-na/


Feedback
contact admin@hum-molgen.org


Advertise at HUM-MOLGEN
http://hum-molgen.org/flyer/advertise.pdf
contact FS Zollmann (dialogue@hum-molgen.org)

__________________________________________________________________________

   DRUG DISCOVERY TECHNOLOGY EUROPE 2006
   Conference & Exhibition

   13-16 March 2006 - London, UK

   http://hum-molgen.org/promotion-DDT
__________________________________________________________________________ 





   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2005 HUM-MOLGEN. All rights reserved. Liability and Copyright.